. Long-Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease. Mov Disord. 2021 Mar;36(3):740-749. Epub 2020 Nov 20 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Nilotinib